Europe, Middle East & Africa
Find the right study design.
Ensure your study demonstrates your product's value and drives better patient outcomes. We will help you design the right study for your needs.
Smarter ways to generate evidence
The increasing costs of developing treatments requires smarter approaches. Access a wide spectrum of data and sourcing approaches from existing secondary data, primary data, registry collaborations, and patient reported outcomes. Tap into our fit-for-purpose study designs.
Every study is different. The IQVIA CORE supports specific research needs built on our domain expertise, unparalleled data, transformative technology and advanced analytics.
IQVIA is the perceived RWE market thought leader and expert across RWD sources and proper use, RWD analytical capabilities and RWE generation – by a significant margin.Source - Life Science Strategy Group, LLC – Real World Evidence Report
Smarter study approaches
We are reimagining evidence generation with innovative approaches you can leverage right now, today.
- Enriched Study Methodology: Integrate secondary data from non-identified databases (such as EMRs, Claims, Research cohorts) with primary data from physicians and patients to build a comprehensive patient record specific to your research.
- External Comparator Studies: Provide context for single-arm trials using real world data, increase operational efficiencies and answer Regulators’ and Payors’ requirements with confidence.
- Extension Studies: Meet additional research objectives by keeping patients and investigators engaged post-trial. Drive efficiencies and capture long-term patient outcomes to understand the long-term safety and effectiveness of your drug.
- Pragmatic Trials: Generate Real World Evidence to evaluate the effectiveness of a randomized intervention in real-life conditions, helping you answer Regulators’ and Payers questions on your product.
Accelerated recruitment
IQVIA has delivered 67% faster recruitment time with enriched studies. By connecting with existing real world data sources, we can more easily find the right patients and quickly move to recruitment.
Regulatory knowledge
Current working knowledge helps ensure that your studies meet regulatory standards. As active partners and participants with OMOP, ENCePP, EUnetHTA, IMI, the Department of Health and Human Services and others, IQVIA is committed to remaining current for the benefit of our customers.
Learn how to develop a framework to qualify RWE in the context of a particular study.
Learn more about the federated evidence networks and massive, non-identified global databases that inform our real world solutions.
Automate and customize data analysis and get the most out of your portfolio with scalable platforms.